No Data
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
Firebrick Pharma Ltd: Appendix 4D & Half-Year Financial Report to 31 December 2024
Firebrick Pharma Signs License, Distribution Agreement to Sell Nasal Spray in Fiji, South Pacific, Shares Down 4%
Firebrick Pharma Removes Nasal Spray Competitor in Singapore for Patent Violation
Firebrick Pharma Obtains COVID-19 Patent for Nasodine in Mexico
Australian Shares Flat as CPI Slows in August; Sigma Healthcare Hits New 52-Week High After H1 Results